Sunday, February 22, 2026

Latest:

How one Veteran found his purpose through CWT
Medicare Advantage’s ‘sunk-cost’ problem
Should Drug Companies Be Advertising to Consumers?
Medicaid Managed Care Reporting and Transparency: Managed Care Program Annual Reports
BCBS Michigan scores $147M in savings through biosimilars

Home
About
- AMAC Foundation
What is medicare?
Enrolling in Medicare
Medicare History
- Medicare’s Major Milestones
COVID-19 Information

Part D/Prescription Drugs

Arlene Sharp December 31, 2024December 31, 2024 Healthcare Costs, medicare, Medicare Part D

Statement from President Biden on Medicare’s New $2,000 Cap on Prescription Drug Costs Taking Effect

The White House December 31, 2024 I believe that health care should be a right – not a privilege –

Congressional Budget Office (CBO)Health Care - General Medicare - General Part D/Prescription Drugs

Arlene Sharp December 30, 2024December 30, 2024

Extending Medicare coverage to obesity medications is imperative

By Anand Parekh, William Dietz, and Joseph Nadglowski for STAT on December 30, 2924 Although bipartisan legislation to provide Medicare coverage for obesity treatments

Health Care Finance Part D/Prescription Drugs

Eileen Cook December 24, 2024December 24, 2024 Healthcare Finance, Inflation Reduction Act of 2022, medicare, Medicare Part D

How Medicare Negotiated Drug Prices Compare to Other Countries

(By Delaney Tevis, Matt McGough, Juliette Cubanski, and Cynthia Cox for The Kaiser Family Foundation Published: Dec 19, 2024) This

FDA Part D/Prescription Drugs

Eileen Cook December 24, 2024 FDA, Generic Drugs, GLP-1 drugs, Victoza

FDA approves GLP-1 generic

(By Paige Twenter for Becker’s Hospital Review) On Dec. 23, the FDA approved Hikma Pharmaceuticals’ liraglutide injection, a generic version

FDA Part D/Prescription Drugs

Eileen Cook December 23, 2024December 23, 2024 FDA, sleep apnea, Weight-loss drugs, Zepbound

FDA approves weight loss drug Zepbound to treat obstructive sleep apnea

(By Juliana Kim for NPR) The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive

Aging Part D/Prescription Drugs

Eileen Cook December 20, 2024December 20, 2024 Acetaminophen, Older Adults

Acetaminophen can cause medical complications in people over 60: 4 study takeaways

(By Alexandra Murphy for Becker’s Hospital Review) A study published Nov. 24 in Arthritis Care & Research highlighted serious health

Health Care Finance Health Insurance Legal Actions/Court Decisions Part D/Prescription Drugs PBM's

Eileen Cook December 18, 2024December 18, 2024 Healthcare Finance, Medicare Part D, PBM Industry

How a Duty To Spend Wisely on Worker Benefits Could Loosen PBMs’ Grip on Drug Prices

(By Arthur Allen for KFF Health News) Ann Lewandowski knows all about pharmacy benefit managers, or PBMs, the companies that

HRSA Part D/Prescription Drugs

Eileen Cook December 17, 2024December 17, 2024 340B drug discount program, HHS, HRSA, Medicare Part D, Wholesaler Acquisition Cost

HRSA warns Sanofi over 340B rebate proposal

(By Alexandra Murphy for Becker’s Hospital Review) The Health Resources and Services Administration has issued a warning to Sanofi over

CMS Health Care Finance Health Care Redesign Medicare Advantage Part D/Prescription Drugs

Eileen Cook December 17, 2024December 17, 2024 CMS, Healthcare Costs, Healthcare Finance, medicare, Medicare Advantage, Medicare Part D, Older Adults

5 Medicare Advantage changes coming in 2025

(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage plans must comply with new network adequacy and health equity standards

Health Insurance Legislative Update Part D/Prescription Drugs

Eileen Cook December 16, 2024December 16, 2024 Anti-competitive practices, Congressional Probe, PBM

Lawmakers probe CVS Caremark over potential anti-competitive practices

(By Alexandra Murphy for Becker’s Hospital Review) House Republicans are investigating whether CVS Caremark, a leading pharmacy benefit manager, violated

← Previous
Next →